Nikon Inc.
Nikon to Provide COOLSHOT Rangefinders to All Active Athletes Across Both Tours
DAYTONA BEACH, FL / ACCESSWIRE / April 24, 2024 / The Ladies Professional Golf Association (LPGA) and Ladies European Tour (LET) proudly announce a new multi-year partnership with Nikon Inc., a leader in imaging products, optics, precision equipment and instruments.
Nikon's COOLSHOT Rangefinders will become the Official Rangefinders of both Tours, offering precision optical devices designed to deliver unparalleled accuracy in distance measurement. With cutting-edge technology and sleek design, Nikon Rangefinders promise superior performance in diverse scenarios, blending precision, innovation, and durability seamlessly to empower confident decision-making during play.
"To Nikon, this is more than a partnership - it's a fantastic opportunity to support a diverse group of amazing and talented athletes, who can use our optics and rangefinders to take their already impressive game even further," said Naoki Onozato, President and CEO, Nikon Inc. "We can't wait to see how these tours grow and thrive in the future, and we are proud to be a part of it."
As part of the partnership, LPGA and LET players will receive Nikon Rangefinders for use during competition and practice, with the rangefinders featuring a special competition mode to comply with the Rules of Golf. Nikon's commitment underscores its dedication to equipping athletes with the tools necessary for success at the highest level.
"We are so thrilled to announce Nikon as our newest official partner, providing high-quality equipment that supports the success of our athletes," said LPGA Chief Sales and Partnerships Officer Nicole Metzger. "This partnership directly benefits our athletes by providing them with top-of-the-line equipment that enhances their performance and confidence on the course. We are constantly looking to work with corporations like Nikon who share our dedication to growing and elevating the sport and empowering female athletes worldwide."
Rangefinders were first allowed in LPGA Tour competition at the 2021 KPMG Women's PGA Championship, with athletes now permitted to use rangefinder technology at most LPGA Tour and LET events. The Epson Tour and LET Access Series have permitted the usage of rangefinders in competition since 2020.
"We are excited to welcome Nikon to the LET family as the Official Rangefinder to the Tour for the next two years," said Fiona Harold, Commercial Director of the LET. "It's key for us that we align with partners who support our objectives, and this is a great example of that. Nikon's investment means our players will benefit from using the best equipment to enable them to excel on the golf course. Their commitment to partnering with both the LET and the LPGA shows the value they place on supporting elite female golfers competing across the globe. We are really looking forward to working with them."
For more information and to explore the products offered by Nikon, visit NikonUSA.com.
Full PR here: https://www.nikonusa.com/press-room/lpga
Contact Information
Geoff Coalter
Communications Strategy and PR Manager
geoffrey.coalter@nikon.com
201-289-7871
J.D Sterba
Director, Public Relations & Executive Communications
jd.sterba@lpga.com
SOURCE: Nikon Inc.
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release
MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T
Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release
Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e
Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release
Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress
Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut
RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
